REG - Constellation Health - Trading Update <Origin Href="QuoteRef">SAFE.L</Origin>

Safestore HoldingsAnnouncement

28/01/2015 02:05

RNS Number : 8134C
Constellation Healthcare Tech, Inc
22 January 2015
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. 
22 January 2014
Constellation Healthcare Technologies, Inc.
("Constellation Healthcare Technologies" or the "Company")
Trading Update 
Constellation Healthcare Technologies, the healthcare services organisation, is pleased to provide the following trading update for the year to 31 December 2014.
The Company was successfully admitted to trading on the AIM Market of the London Stock Exchange on 8 December 2014, raising approximately 9.6 million. The Company expects to report revenue and EBITDA marginally ahead of management expectations for the year ended 31 December 2014. 
Paul Parmar, Chief Executive Officer of Constellation Healthcare Technologies, said:
"During 2014 Constellation Healthcare Technologies made good progress on its strategy of building its client base, driving operational efficiencies and pursuing acquisition opportunities. We are delivering on the promises we set out at the time of the IPO and look forward to updating shareholders at our full year results." 
For further information regarding Constellation Healthcare Technologies please call:
Constellation Healthcare Technologies
Paul Parmar, Chief Executive Officer
Ravi Chivukula, Chief Financial Officer
c/o Redleaf Polhill 
+44 (0)20 7382 4730
Redleaf Polhill - PR adviser
Rebecca Sanders-Hewett / Charlie Geller / David Ison
+44 (0)20 7382 4730
constellation@redleafpr.com
finnCap - Nominated Adviser and Broker
Julian Blunt / Scott Mathieson
+44 (0)20 7220 0568
Chrystal Capital - Broker
James Innes / Richard Goldsmith
+44 (0)20 7850 4762

This information is provided by RNS
The company news service from the London Stock Exchange
  END
TSTLLFLTLFILFIE